Dr. Hee-Young Park, Assistant Dean of GMS and a faculty member of the Dermatology and Biochemistry departments, received both B.S. and Ph.D. degrees from MIT. Born in Seoul, Korea, Dr. Park moved to Sapporo, Japan with her family for middle school. She then came to Fayetteville, Arkansas for high school and remained in the U.S. to pursue her interests in science. Dr. Park’s research for past two decades has focused on signaling pathways and factors that control skin color, aging and cutaneous wound healing. In addition to her research activities, she has consulted cosmetic and pharmaceutical companies interested in developing treatments for pigmentation-disorders and holds a patent for a method to decrease skin pigmentation. Dr. Park also has a long-standing interest in teaching and mentoring students. She has served as a faculty advisor and mentor to graduate students, medical students, residents and post-doctoral fellows. She hopes to continue to devote her time to serving the GMS community and helping all GMS students to have enriched educational experiences that will best prepare them for their future careers.
- Professor, Dermatology (excluding Mohs Surgery), Dermatology, Boston University School of Medicine
- Associate Dean for Faculty Affairs, Boston University School of Medicine
- Chair, Medical Sciences & Education, Boston University School of Medicine
- Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Division of Graduate Medical Sciences
- Massachusetts Institute of Technology, PhD
- Massachusetts Institute of Technology, BS
- Published on 4/3/2018
Park HY, Berkowitz O, Symes K, Dasgupta S. The art and science of selecting graduate students in the biomedical sciences: Performance in doctoral study of the foundational sciences. PLoS One. 2018; 13(4):e0193901. PMID: 29614110.
- Published on 12/1/2014
Mitchell B, Leone D, Feller JK, Bondzie P, Yang S, Park HY, Mahalingam M. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status. Melanoma Res. 2014 Dec; 24(6):621-5. PMID: 25211166.
- Published on 10/1/2014
Belisle ES, Park HY. Metformin: a potential drug to treat hyperpigmentation disorders. J Invest Dermatol. 2014 Oct; 134(10):2488-91. PMID: 25219649.
- Published on 7/2/2014
Mitchell B, Leone D, Feller K, Menon S, Bondzie P, Yang S, Park HY, Mahalingam M. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility? Hum Pathol. 2014 Oct; 45(10):2094-100. PMID: 25130395.
- Published on 12/1/2012
Bae-Harboe YS, Park HY. Tyrosinase: a central regulatory protein for cutaneous pigmentation. J Invest Dermatol. 2012 Dec; 132(12):2678-80. PMID: 23187110.
- Published on 12/8/2011
Yaar M, Park HY. Melanocytes: a window into the nervous system. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):835-45. PMID: 22158549.
- Published on 3/1/2011
Kloxin CJ, Scott TF, Park HY, Bowman CN. Mechanophotopatterning on a photoresponsive elastomer. Adv Mater. 2011 May 3; 23(17):1977-81. PMID: 21360784.
- Published on 3/1/2011
Jung M, Lee S, Park HY, Youm JK, Jeong S, Bae J, Kwon MJ, Park BD, Lee SH, Choi EH. Anti-ageing effects of a new synthetic sphingolipid (K6EAA-L12) on aged murine skin. Exp Dermatol. 2011 Apr; 20(4):314-9. PMID: 21366697.
- Published on 11/2/2010
Park HY, Kim JH, Ji JH, Ahn SK, Hong SP. Variant of phacomatosis pigmentokeratotica. J Dermatol. 2011 Jul; 38(7):719-22. PMID: 21352309.
- Published on 6/1/2010
Byers HR, Boissel SJ, Tu C, Park HY. RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line. Melanoma Res. 2010 Jun; 20(3):171-8. PMID: 20216103.
View 16 more publications: View full profile at BUMC